Dapagliflozin Initiation and eGFR Trajectories Across uACR Subgroups in Clinical Practice

Introduction: Dapagliflozin clinical data have shown a reduced decline in estimated glomerular filtration rate (eGFR) among treated patients compared with placebo. We describe eGFR changes following dapagliflozin initiation in clinical practice across urine albumin-creatinine ratio (uACR) subgroups (low: <200mg/g, high: ≥200mg/g, unknown).